BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36676654)

  • 1. Incidental Hepatocellular Carcinoma after Liver Transplantation: Clinicopathologic Features and Prognosis.
    Ozdemir F; Ince V; Usta S; Carr BI; Bag HG; Akatli AN; Kahraman AS; Yilmaz S
    Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, Characteristics, and Prognosis of Incidentally Discovered Hepatocellular Carcinoma after Liver Transplantation.
    El Moghazy W; Kashkoush S; Meeberg G; Kneteman N
    J Transplant; 2016; 2016():1916387. PubMed ID: 27403337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of incidentally detected hepatocellular carcinoma in explanted livers after living donor liver transplantation.
    Rajakannu M; Vij M; Shaikh TMA; Rammohan A; Reddy MS; Rela M
    Indian J Gastroenterol; 2021 Feb; 40(1):30-34. PubMed ID: 33548018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidental hepatocellular carcinoma after liver transplantation: Prevalence, histopathological features and prognostic impact.
    Pérez P; Rodríguez-Perálvarez M; Guerrero L; González V; Sánchez R; Centeno M; Poyato A; Briceño J; Sánchez-Frías M; Montero JL; De la Mata M
    PLoS One; 2017; 12(4):e0175010. PubMed ID: 28403219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
    Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
    Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidentally discovered hepatocellular carcinoma in explanted liver: clinical, histopathologic features and outcome.
    Madaleno J; Alves R; Silva N; Calretas S; Tomé L; Ferrão J; Barros A; Diogo D; Cipriano A; Furtado E; Carvalho A
    Transplant Proc; 2015 May; 47(4):1051-4. PubMed ID: 26036517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is recurrence rate of incidental hepatocellular carcinoma after liver transplantation similar to previously known HCC? towards a predictive recurrence score.
    Piñero F; Mendizabal M; Casciato P; Galdame O; Quiros R; Bandi J; Mullen E; Andriani O; de Santibañes E; Podestá LG; Gadano A; Silva M
    Ann Hepatol; 2014; 13(2):211-8. PubMed ID: 24552863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidental hepatocellular carcinoma: risk factors and long-term outcome after liver transplantation.
    Senkerikova R; Frankova S; Sperl J; Oliverius M; Kieslichova E; Filipova H; Kautznerova D; Honsova E; Trunecka P; Spicak J
    Transplant Proc; 2014 Jun; 46(5):1426-9. PubMed ID: 24935308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of Liver Transplantation for Hepatocellular Carcinoma in a Multicenter Latin American Cohort Study.
    Piñero F; Costa P; Boteon YL; Duque SH; Marciano S; Anders M; Varón A; Zerega A; Poniachik J; Soza A; Machaca MP; Menéndez J; Zapata R; Vilatoba M; Muñoz L; Maraschio M; Fauda M; McCormack L; Gadano A; Boin IS; García JHP; Silva M
    Ann Hepatol; 2018 Mar; 17(2):256-267. PubMed ID: 29469048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors for extrahepatic recurrence of hepatocellular carcinoma following liver transplantation.
    Andreou A; Bahra M; Schmelzle M; Öllinger R; Sucher R; Sauer IM; Guel-Klein S; Struecker B; Eurich D; Klein F; Pascher A; Pratschke J; Seehofer D
    Clin Transplant; 2016 Jul; 30(7):819-27. PubMed ID: 27107252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longterm prognosis of combined hepatocellular carcinoma-cholangiocarcinoma following liver transplantation and resection.
    Jung DH; Hwang S; Song GW; Ahn CS; Moon DB; Kim KH; Ha TY; Park GC; Hong SM; Kim WJ; Kang WH; Kim SH; Yu ES; Lee SG
    Liver Transpl; 2017 Mar; 23(3):330-341. PubMed ID: 28027599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence of hepatocellular cancer after liver transplantation: the role of primary resection and salvage transplantation in East and West.
    Lai Q; Avolio AW; Lerut J; Singh G; Chan SC; Berloco PB; Tisone G; Agnes S; Chok KS; Sharr W; Rossi M; Manzia TM; Lo CM
    J Hepatol; 2012 Nov; 57(5):974-9. PubMed ID: 22771712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and outcome of incidental hepatocellular carcinoma after liver transplantation: a cohort study.
    Ríos León R; Sánchez Rodríguez E; Martínez Ortega A; Rodríguez de Santiago E; Marcos Carrasco N; Graus Morales J; Rodríguez Gandía MÁ; Lledó Navarro JL; Gea Rodríguez F; Nuño Vázquez Garza JM; Albillos Martínez A; García González M
    Rev Esp Enferm Dig; 2022 Apr; 114(4):219-225. PubMed ID: 33733806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus-infected liver transplant recipients with incidental hepatocellular carcinoma: A prospective multicenter nationwide cohort study.
    Agüero F; Forner A; Valdivieso A; Blanes M; Barcena R; Manzardo C; Rafecas A; Castells L; Abradelo M; Barrera-Baena P; González-Diéguez L; Salcedo M; Serrano T; Jiménez-Pérez M; Herrero JI; Gastaca M; Aguilera V; Fabregat J; Del Campo S; Bilbao I; Romero CJ; Moreno A; Rimola A; Miro JM;
    Liver Transpl; 2017 May; 23(5):645-651. PubMed ID: 28188668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do We Need to Be Limited by Matching Milan Criteria for Survival in Living Donor Liver Transplantation?
    Akbulut S; Koc C
    J Gastrointest Cancer; 2020 Dec; 51(4):1107-1113. PubMed ID: 32857265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propensity-Matched Analysis of Patients with Mixed Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma Undergoing Liver Transplantation.
    Lunsford KE; Court C; Seok Lee Y; Lu DS; Naini BV; Harlander-Locke MP; Busuttil RW; Agopian VG
    Liver Transpl; 2018 Oct; 24(10):1384-1397. PubMed ID: 29573187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter validation of a score to predict prognosis after the development of HCC recurrence following liver transplantation.
    Goldaracena N; Mehta N; Scalera I; Sposito C; Atenafu EG; Yao FY; Muiesan P; Mazzaferro V; Sapisochin G
    HPB (Oxford); 2019 Jun; 21(6):731-738. PubMed ID: 30391218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation and incidentally found hepatocellular carcinoma in liver explants: need for a new definition?
    Sotiropoulos GC; Malagó M; Molmenti EP; Nadalin S; Radtke A; Brokalaki EI; Lang H; Frilling A; Baba HA; Neuhäuser M; Broelsch CE
    Transplantation; 2006 Feb; 81(4):531-5. PubMed ID: 16495799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of selected criteria and preventive chemotherapy in tumor recurrence after liver transplantation.
    Wang MX; Chen D; Zhao YY; Yang B; Jiang JP; Zeng FJ; Wei L; Chen ZS
    Hepatobiliary Pancreat Dis Int; 2020 Aug; 19(4):378-383. PubMed ID: 32622825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of Early Recurrence of Hepatocellular Carcinoma in Patients with Cirrhosis Who Had Received Deceased Donor Liver Transplantation: A Multicenter Study.
    Al-Ameri AAM; Wei X; Liu P; Lin L; Shao Z; Xie H; Zhou L; Zheng S; Xu X
    Ann Transplant; 2019 Aug; 24():489-498. PubMed ID: 31427563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.